Help us: Donate
Follow us on:

Cyclarity Therapeutics

Organization Description


Cyclarity Therapeutics (formerly known as Underdog Pharmaceuticals), is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.


Michael Kope

Cyclarity Therapeutics - CEO of Corporate Affairs

Matthew O'Connor

Cyclarity Therapeutics - CEO of Scientific Affairs

Want the latest longevity news? Subscribe to our Newsletter!